Evaluation of Cardamom Based Gel in Treatment of Gum Diseases

Optimizing Local Drug Delivery - A Study Evaluating the Application of Cardamom Gel Loaded in Custom Molded Trays for Enhancing Nonsurgical Management of Generalized Stage II and Stage III Periodontitis. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070158

Enrollment

Registered

2024-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Thermoreversible cardamom gel: To assess whether the application of thermoreversible cardamom gel loaded in custom molded trays in addition to traditional non-surgical periodontal thera

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects diagnosed with periodontitis as per the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. 2. Subjects who have not undergone any periodontal therapy in the past six months

Exclusion criteria

Exclusion criteria: 1. Participants with systemic diseases that could affect periodontal health (e.g., uncontrolled diabetes). 2. Participants currently undergoing periodontal treatment. 3. History of antibiotic use within the past three months.

Design outcomes

Primary

Measure	Time frame
1.Reductions in probing pocket depth, gains in clinical attachment levels 2.Improvements in periodontal inflammatory markers 3.Reduction in red complex bacterial presence Timepoint: 3 months	—

Secondary

Measure	Time frame
Improvement in patient-reported outcomes such as oral health-related quality of life Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Jayan Jacob Mathew

Mar Baselios Dental College

jayanjm@gmail.com9447160349

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026